5 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18268632 | 1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC AND AUTOIMMUNE DISEASES | BRAUN, MADELINE E | 1624 | Non-Final OA | Jun 21, 2023 |
| 18020980 | DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BTK AND MUTANTS THEREOF | ENGLISH, CONNOR KENNEDY | 1625 | Final Rejection | Feb 13, 2023 |
| 17798904 | HOT MELT EXTRUDED SOLID DISPERSIONS CONTAINING A BCL2 INHIBITOR | PECKHAM, RICHARD GRANT | 1627 | Non-Final OA | Aug 11, 2022 |
| 17764329 | INHIBITOR OF BTK AND MUTANTS THEREOF | STOCKTON, LAURA LYNNE | 1626 | Final Rejection | Mar 28, 2022 |
| 17764285 | CONDENSED HETEROCYCLES AS BCL-2 INHIBITORS | HEASLEY, MEGHAN CHRISTINE | 1626 | Non-Final OA | Mar 28, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial